UK markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5400+0.2600 (+20.31%)
At close: 04:00PM EDT
1.5400 0.00 (0.00%)
After hours: 04:11PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
7,825
9,561
9,133
8,820
Selling general and administrative
13,412
13,527
8,081
9,161
Total operating expenses
21,238
23,088
17,214
17,981
Operating income or loss
-21,238
-23,088
-17,214
-17,981
Total other income/expenses net
11,251
5,294
-220.701
885.742
Income before tax
-9,890
-17,748
-17,424
-17,082
Income from continuing operations
-9,890
-17,748
-17,424
-17,082
Net income
-9,890
-17,748
-17,424
-17,082
Net income available to common shareholders
-9,890
-17,748
-17,424
-17,082
Basic EPS
-2.52
-5.40
-8.12
-11.20
Diluted EPS
-2.52
-5.40
-8.12
-11.20
Basic average shares
3,907
3,122
2,146
1,123
Diluted average shares
3,907
3,122
2,146
1,580